Prolific Machines vs Pliant Therapeutics
Side-by-side comparison of AI visibility scores, market position, and capabilities
Light-Activated Cell Growth & Biomanufacturing Technology
Prolific Machines is a Berkeley-based biotech company using light to control cell growth and differentiation, dramatically reducing bioreactor costs for cultivated meat and cell therapy; raised $55M+ including a $36M Series B in 2023;
About
Prolific Machines is a Berkeley, California-based biomanufacturing technology company founded in 2020 by Deniz Kent, Joshua Mich, and Declan Jones that has developed a pioneering approach to cell biology: using light — specifically engineered light-sensitive proteins (optogenetics) — to control the growth and differentiation of stem cells and other mammalian cells in bioreactors. Traditional cell culture requires expensive biological growth factors (proteins such as FGF2 and TGF-β) added to culture media to drive cell proliferation and differentiation. Prolific Machines'' technology replaces or dramatically reduces the need for these expensive growth factor inputs by using light signals to activate engineered receptors within cells — achieving the same biological responses at a fraction of the cost.
Pliant Therapeutics is a clinical-stage biotech (Nasdaq: PLRX) developing integrin inhibitors for fibrotic diseases, with lead program bexotegrast in Phase 2b/3 trials for idiopathic pulmonary fibrosis.
About
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH/MASH). Integrins are cell surface receptors that activate TGF-β, the master regulator of fibrosis — blocking specific integrin subtypes (αvβ6, αvβ1) can halt or reverse fibrosis progression without broadly suppressing immunity.
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Prolific Machines vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.